Allergies News and Research

Latest Allergies News and Research

New gene therapy cures babies with fatal 'Bubble Boy' disease

A new gene therapy created by US researchers appears to have cured eight infant boys born with a rare genetic disorder referred to as “Bubble Boy” disease.

18 Apr 2019

Gut bacteria and pregnancy

Researchers from Bar-Ilan University have found that with pregnancy there is a change in the composition of gut bacteria in women. This could be associated with the changing hormonal status they speculate. The results of their study titled, “Progesterone Increases Bifidobacterium Relative Abundance during Late Pregnancy,” were published in the latest issue of the journal Cell Reports.

17 Apr 2019

C-Path and CDISC release global Therapeutic Area Standard for HIV research

The Critical Path Institute and CDISC are pleased to announce the release of a global Therapeutic Area Standard that specifies how to structure commonly collected data and outcome measurements in clinical trials for HIV.

17 Apr 2019

Study identifies novel loci contributing to asthma susceptibility in adults

A large, multi-ethnic genome-wide association study (GWAS) of asthma identified novel associations with potential relevance for asthma susceptibility in older adults of diverse racial backgrounds.

17 Apr 2019

Unreliable diagnostics for fish allergy testing

James Cook University scientists in Australia have found material commonly used for fish allergy testing is unreliable - potentially putting lives at risk.

12 Apr 2019

Particle-depleted diesel exhaust may worsen allergy-induced lung impairment

Air pollution from diesel engines may worsen allergy-induced lung impairment more when tiny particles are filtered from the exhaust than when they are not, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

12 Apr 2019

Living transplant donors also need long-term monitoring to prevent adverse events

While organ transplant recipients receive continual care as the end-stage treatment to their condition, attention also should be given to living donors, who can suffer from hypertension, diabetes and other disorders after donation, according to a study by researchers at UC San Francisco.

11 Apr 2019

Sexual behavior could affect gut microbiome and immune system

A person's sexual behavior could affect their microbiome and immune system, potentially elevating their risk of HIV infection, according to a new study from researchers at the University of Colorado Anschutz Medical Campus.

10 Apr 2019

Researchers identify alternative treatment for bacterial meningitis

With the increasing threat of antibiotic resistance, there is a growing need for new treatment strategies against life threatening bacterial infections.

10 Apr 2019

Researchers map genetic mutation behind incurable disease

Researchers at Karolinska Institutet have mapped the genetic mutation behind the incurable disease systemic mastocytosis.

10 Apr 2019

Why hay fever persists, despite low pollen counts

A team of researchers are investigating why despite low forecasts of pollen counts, on some days, there is a higher incidence of hay fever.

10 Apr 2019

Eight-year study identifies potential new way to treat extreme childhood food allergy

An eight-year hunt for the cells that drive the extreme childhood food allergy eosinophilic esophagitis has identified a potential new way to treat the disease while also raising questions about a dietary supplement often taken to reduce bowel inflammation.

9 Apr 2019

FASTER Act will help improve lives of 32 million Americans with food allergies

Today, the Food Allergy Safety, Treatment, Education and Research (FASTER) Act, a package of federal policy changes that will improve the health, safety and inclusion of the 32 million Americans living with food allergies, was introduced by Rep. Doris Matsui (D-CA).

9 Apr 2019

UTMB receives grant to combat highly-lethal hemorrhagic fever viruses

The University of Texas Medical Branch at Galveston, Profectus Biosciences, Vanderbilt University Medical Center, Mapp Biopharmaceutical and Genevant Sciences Corp. have been awarded up to $35 million to advance the development of rapid-acting vaccines and broad-spectrum treatments of the highly-lethal hemorrhagic fever viruses Ebola and Marburg.

9 Apr 2019